Cortexyme, Inc. (CRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
49.42+0.81 (+1.67%)
At close: 1:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 48.61 |
| Open | 48.68 |
| Bid | 48.00 x 800 |
| Ask | 54.90 x 1100 |
| Day's Range | 47.37 - 49.42 |
| 52 Week Range | 26.99 - 73.84 |
| Volume | 91,928 |
| Avg. Volume | 114,149 |
| Market Cap | 1.458B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.35 |
| Earnings Date | Nov 12, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.43 |
- Zacks
New Strong Sell Stocks for November 27th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
- Zacks
New Strong Sell Stocks for November 20th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.
- Business Wire
Cortexyme Announces Third Quarter 2020 Financial Results and Provides Business Update
Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering potential therapeutics for Alzheimer’s and other degenerative diseases, today announced financial results for the third quarter 2020 and provided an update on its business.
© 2020 Verizon Media. All rights reserved.
